-
1
-
-
0029664707
-
Das Wirkungs- und Sicherheitsprofil von Fumarsäureestern in der oralen Langzeittherapie bei schwerer therapieresistenter Psoriasis vulgaris
-
Altmeyer P et al.: Das Wirkungs- und Sicherheitsprofil von Fumarsäureestern in der oralen Langzeittherapie bei schwerer therapieresistenter Psoriasis vulgaris. Hautarzt 1996; 46: 190-196
-
(1996)
Hautarzt
, vol.46
, pp. 190-196
-
-
Altmeyer, P.1
-
2
-
-
20244383720
-
Antipsoriatic effect of fumaric acid derivates. Results of a multicenter double-blind study in 100 patients
-
Altmeyer P et al.: Antipsoriatic effect of fumaric acid derivates. Results of a multicenter double-blind study in 100 patients. J Am Acad Dermatol 1994; 30: 977-981
-
(1994)
J Am Acad Dermatol
, vol.30
, pp. 977-981
-
-
Altmeyer, P.1
-
3
-
-
0032834958
-
Fumaric acid esters: An alternative systemic treatment for psoriasis
-
Ameen M, Russell-Jones R: Fumaric acid esters: an alternative systemic treatment for psoriasis. Clin Dermatol 1999; 24: 361-364
-
(1999)
Clin Dermatol
, vol.24
, pp. 361-364
-
-
Ameen, M.1
Russell-Jones, R.2
-
4
-
-
0023198020
-
Perorale Langzeitbehandlung der Psoriasis mit Fumarsäurederivate
-
Bayard W et al.: Perorale Langzeitbehandlung der Psoriasis mit Fumarsäurederivate. Hautarzt 1987; 38: 279-285
-
(1987)
Hautarzt
, vol.38
, pp. 279-285
-
-
Bayard, W.1
-
5
-
-
0034912675
-
Dithranol and dimethylfumarate suppress the interferon-gamma-incluced up-regulation of cytokeratin 17 as a putative psoriasis autoantigen in vitro
-
Bonnekoh B et al.: Dithranol and dimethylfumarate suppress the interferon-gamma-incluced up-regulation of cytokeratin 17 as a putative psoriasis autoantigen in vitro. Skin Pharmacol Appl Skin Physiol. 2001; 14 (4): 217-225
-
(2001)
Skin Pharmacol Appl Skin Physiol
, vol.14
, Issue.4
, pp. 217-225
-
-
Bonnekoh, B.1
-
6
-
-
0032836649
-
Management of psoriasis in childhood
-
Burden AD: Management of psoriasis in childhood. Clin Exp Dermatol 1999; 24 (5): 341-345
-
(1999)
Clin Exp Dermatol
, vol.24
, Issue.5
, pp. 341-345
-
-
Burden, A.D.1
-
7
-
-
0002767960
-
Psoriasis - Ein vielgestaltiges Krankheitsbild
-
Christophers E, Mrowietz U: Psoriasis - ein vielgestaltiges Krankheitsbild. Dt Ärztebl 1999; 96 (36): A-2220-2226
-
(1999)
Dt Ärztebl
, vol.96
, Issue.36
-
-
Christophers, E.1
Mrowietz, U.2
-
8
-
-
0033228091
-
Childhood psoriasis
-
Farber EM, Nall L: Childhood psoriasis. Cut 1999; 64 (5): 309-314
-
(1999)
Cut
, vol.64
, Issue.5
, pp. 309-314
-
-
Farber, E.M.1
Nall, L.2
-
9
-
-
0028912957
-
UVB phototherapy in childhood psoriasis
-
al-Fouzan AS, Nanda A: UVB phototherapy in childhood psoriasis. Pediatr Dermatol 1995; 12 (1): 66
-
(1995)
Pediatr Dermatol
, vol.12
, Issue.1
, pp. 66
-
-
Al-Fouzan, A.S.1
Nanda, A.2
-
11
-
-
0037312626
-
Macular Exanthema due to Fumaric Acid Esters
-
Günther CH et al.: Macular Exanthema due to Fumaric Acid Esters. Ann Pharmacother 2003; 234-236
-
(2003)
Ann Pharmacother
, pp. 234-236
-
-
Günther, C.H.1
-
12
-
-
2642687679
-
Fumaric acid esters suppress peripheral CD4-and CD8-positive lymphocytes in psoriasis
-
Höxtermann S et al.: Fumaric acid esters suppress peripheral CD4-and CD8-positive lymphocytes in psoriasis. Dermatol 1998; 196: 223-230
-
(1998)
Dermatol
, vol.196
, pp. 223-230
-
-
Höxtermann, S.1
-
13
-
-
0029846154
-
Selective stimulation of T helper 2 cytokine responses by the anti-psoriasis agent monomethylfumarate
-
De Jong P et al.: Selective stimulation of T helper 2 cytokine responses by the anti-psoriasis agent monomethylfumarate. Eur J Immunol 1996; 26: 2067-2074
-
(1996)
Eur J Immunol
, vol.26
, pp. 2067-2074
-
-
De Jong, P.1
-
14
-
-
0026737371
-
Fumaric acid therapy in psoriais: Results and side-effects of two years of treatment
-
Kolbach DN, Nieboer C: Fumaric acid therapy in psoriais: Results and side-effects of two years of treatment. J Am Acad Dermatol 1992; 27: 769-71
-
(1992)
J Am Acad Dermatol
, vol.27
, pp. 769-771
-
-
Kolbach, D.N.1
Nieboer, C.2
-
15
-
-
0028030652
-
Methotrexate in childhood psoriasis
-
Kumar B et al.: Methotrexate in childhood psoriasis. Pediatr Dermatol 1994; 11 (3): 271-273
-
(1994)
Pediatr Dermatol
, vol.11
, Issue.3
, pp. 271-273
-
-
Kumar, B.1
-
16
-
-
0032858530
-
Treatment of severe psoriasis with fumaric acid esters: Scientific background and guidelines for therapeutic use
-
Mrowietz U et al.: Treatment of severe psoriasis with fumaric acid esters: scientific background and guidelines for therapeutic use. Brit J Dermatol 1999; 141: 424-429
-
(1999)
Brit J Dermatol
, vol.141
, pp. 424-429
-
-
Mrowietz, U.1
-
17
-
-
0031896129
-
Treatment of psoriasis with fumaric acid esters: Results of a prospective multicentre study
-
Mrowietz U et al.: Treatment of psoriasis with fumaric acid esters: results of a prospective multicentre study. Brit J Dermatol 1998; 138: 456-60
-
(1998)
Brit J Dermatol
, vol.138
, pp. 456-460
-
-
Mrowietz, U.1
-
18
-
-
0033883511
-
Nephrotoxische Wirkung durch Fumarsäure
-
Mrowietz U: Nephrotoxische Wirkung durch Fumarsäure. Hautarzt 2000; 51: 615
-
(2000)
Hautarzt
, vol.51
, pp. 615
-
-
Mrowietz, U.1
-
19
-
-
0025281268
-
Fumaric acid therapy for psoriasis: A randomised, double-blind, placebo-controlled study
-
Nieboer C et al.: Fumaric acid therapy for psoriasis: a randomised, double-blind, placebo-controlled study. J Am Acad Dermatol 1990; 2: 311-312
-
(1990)
J Am Acad Dermatol
, vol.2
, pp. 311-312
-
-
Nieboer, C.1
-
20
-
-
0031661686
-
The antipsoriatic agent dimethylfumarate immunomodulates T-cell cytokine secretion and inhibits cytokines of the psoriatic cytokine network
-
Ockenfels HM et al.: The antipsoriatic agent dimethylfumarate immunomodulates T-cell cytokine secretion and inhibits cytokines of the psoriatic cytokine network. Br J Dermatol 1998; 139: 390-395
-
(1998)
Br J Dermatol
, vol.139
, pp. 390-395
-
-
Ockenfels, H.M.1
-
21
-
-
0032723844
-
Topical calcipotriol in childhood psoriasis
-
Patrizi A et al.: Topical calcipotriol in childhood psoriasis. Acta Derm Venereol 1999; 79 (6): 477
-
(1999)
Acta Derm Venereol
, vol.79
, Issue.6
, pp. 477
-
-
Patrizi, A.1
-
22
-
-
0038539374
-
Neueste Aspekte in der Pathogenese der Psoriasis
-
Prinz JC: Neueste Aspekte in der Pathogenese der Psoriasis. Hautarzt 2003; 54: 209-214
-
(2003)
Hautarzt
, vol.54
, pp. 209-214
-
-
Prinz, J.C.1
-
23
-
-
0033946247
-
Comparative study of pediatric onset psoriasis with adult onset psoriasis
-
Raychaudhuri S, Gross JA: comparative study of pediatric onset psoriasis with adult onset psoriasis. Pediatr Dermatol 2000; 17: 174-178
-
(2000)
Pediatr Dermatol
, vol.17
, pp. 174-178
-
-
Raychaudhuri, S.1
Gross, J.A.2
-
24
-
-
70449253356
-
Heilung von Psoriasis
-
Schweckendieck W: Heilung von Psoriasis. Med Monatsschr 1959; 13: 103-104
-
(1959)
Med Monatsschr
, vol.13
, pp. 103-104
-
-
Schweckendieck, W.1
-
25
-
-
0028817466
-
Long-term systemic therapy with dimethylfumarate and monoethylfumarate (Fumaderm) in psoriasis
-
Thio HB et al.: Long-term systemic therapy with dimethylfumarate and monoethylfumarate (Fumaderm) in psoriasis. J Eur Acad Dermatol Venerol 1995; 4: 35-40
-
(1995)
J Eur Acad Dermatol Venerol
, vol.4
, pp. 35-40
-
-
Thio, H.B.1
-
26
-
-
0030913951
-
Dimethylfumarate is an inhibitor of cytokine-induced E-selectine, VCAM-1 and ICAM-1 expression in human endothelial cells
-
Vandermeeren M et al.: Dimethylfumarate is an inhibitor of cytokine-induced E-selectine, VCAM-1 and ICAM-1 expression in human endothelial cells. Biochem Biophys Res Commun 1997; 234: 19-23
-
(1997)
Biochem Biophys Res Commun
, vol.234
, pp. 19-23
-
-
Vandermeeren, M.1
-
27
-
-
0028081038
-
Efficacy of short-contact therapy with dithranol in childhood psoriasis
-
Zvulunov A et al.: Efficacy of short-contact therapy with dithranol in childhood psoriasis. Int J Dermatol 1994; 33 (11): 808-810
-
(1994)
Int J Dermatol
, vol.33
, Issue.11
, pp. 808-810
-
-
Zvulunov, A.1
|